€15.50
-0.12 (-0.77%)
EUR · as of 2026-08-17 · marketstack
Clinical trials
catalyst calendar across sponsors →Studies where ELN.MI is the lead sponsor, as filed with ClinicalTrials.gov. Completion dates are the sponsor's own projected windows and are revised as a study runs. Active studies first, then completed and stopped — newest readout first within each.
2 interventional · 2 with posted results
government filings 180d: none disclosed
| Study | Phase | Status | Interventions | Conditions | Enrollment | Primary completion | Updated |
|---|---|---|---|---|---|---|---|
| Clinical Investigation to Assess the Safety and Efficacy of the Laser for the Treatment of Vulvovaginal AtrophyNCT02085980results2021-06-04The Main Outcome of the Study is the Efficacy of the Laser Procedure, Intended as the Amelioration of 50% of the Severity of the Vaginal Dryness at 12 Months, Compared With BaselineOpen-label · Treatment | Not applicable | Completed | Device: Laser treatment | Vulvovaginal Atrophy | 30 | Aug 2015actual | 2021-06-04 |
| TriActive+ Radiofrequency (RF) for Non-Invasive Treatment of Wrinkles and RhytidesNCT01859611results2015-03-11Changes to the Surface by Visual and Photographic Analysis.Open-label · Treatment | Not applicable | Completed | Device: TriActive+ RF | Wrinkles, Rhytides | 51 | Jan 2014actual | 2015-04-07 |
Primary completion is the date the sponsor filed with the registry — their own projection, revised whenever they revise it, unless the row is marked actual.
Source: ClinicalTrials.gov, retrieved 2026-08-19